chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea, vomiting, fever, muscle aches, fatigue, cold chills
Patient was given a non authorized covid-19 bivalent vaccine for age group 6mo-4yrs, non authorized interchangeable for age group, patient started series with Moderna Mono vaccine and was given a Pfizer 6mo-4yrs bivalent, recommends same manufacture for age group.
patient says she has a sciatica issue but it first flared after one of the vaccines and it re-flared after the booster.  She wasn't sure after the first two shots, but now she thinks her nerve problems are related.
Guillain barre syndrome; This case was reported by a pharmacist via call center representative and described the occurrence of guillain barre syndrome in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   It was unknown if the reporter considered the guillain barre syndrome to be related to Shingrix.  Additional information was received as follows: The age at vaccination was not reported. The age group was not reported but it was taken as an adult as per vaccine indicatiion. The pharmist reported that there was a possible Gullian barre syndrome post shingrix in the area. No additional information was provided. The reporter did not consent to follow-up.
Client received Moderna vaccine and walked to the monitoring area. A few minutes into his 15 minutes of monitoring he passed out fell and his head on the floor. Blood pressure 79/40 Pulse 39. He awakened and was able to sit up with help take a few drinks of soda. States he had not ate breakfast. He then stated he started to feel dizziness and wanted to lay back flat on the floor. Blood pressure rechecked and increased to 110/70 with a heart rate on 69. EMSA called and transported him to Medical Center. Followed up with client today and he states they evaluated him in the ER, gave him something to eat and sent him home. States only symptom he has currently is arm soreness.
Pt fussy for 3 days post vacc. Slept and fed poorly, cried off and on, turned pale for about 5 mins, several times. 12/12, developed a rash on head and torso. Saw MD had no signs of infectious illnesses.  No known fever, breast fed.
I think it is an after effect in my knees it is like neuropathy of my knee; knees is very sore; My whole leg feels almost dead; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 76 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: NEUROPATHY PERIPHERAL (medically significant) with onset 2023, outcome "unknown", described as "I think it is an after effect in my knees it is like neuropathy of my knee"; HYPOAESTHESIA (medically significant) with onset 2023, outcome "unknown", described as "My whole leg feels almost dead"; ARTHRALGIA (medically significant) with onset 2023, outcome "unknown", described as "knees is very sore". Therapeutic measures were taken as a result of neuropathy peripheral, arthralgia. Clinical course: Reporter stated that lot of people started with the product. The reporter had two of the vaccines (Clarified as Pfizer Covid-19 Vaccine) that was first coming out and then talked about boosters and had two boosters (Pfizer COVID-19 Booster). The last booster administered to reporter was in September of last year and got COVID in March of the current year and she thought it was an after effect in her knees it was like neuropathy of the knee, whole leg feels almost dead, but the knees is very sore, nervous nerve wise. For the pain the patient took Tylenol; she mentioned her knee but she was also having everyday it did not go away neuropathy in her Achilles tendons on the same leg  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300251724 same patient, different dose/event;
Patient reportedly had non-raised, red, itchy rash start on neck at school that rapidly progressed to face, arms and abdomen.  No difficulty breathing or outward distress.  Patient presented to clinic at 1434.  Tested negative for group A rapid strep. Mother denied any new lotions, soaps or other products that come in contact with skin.
Pt states severe cardiac issues since vax. Presented on 8/24/21 with chills, shortness of breath, low oxygen, weakness, chest pain, vomiting froth, rhonchi/wheezing, all new to the patient.
chills, body aches, abdominal pain, nausea, palpitations, fatigue
Moderna COVID-19 Vaccine EUA: one day after immunization patient admitted to hospital for weakness and confusion. Patient tachycardic but afebrile. Diagnosed with urinary tract infection, administered antibiotics and intravenous fluids, clinically improved and discharged home medically stable.
This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-month-old male patient who received KINRIX (batch number AC20B254AA, expiry date 4th April 2015). Previously administered products included DTAP (dose 1 and dose 2) and IPV (dose 1 and dose 2). On an unknown date, the patient received KINRIX. On an unknown date, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. Additional information: CMA reports KINRIX was administered to a 8 month old as his 3rd DTaP and 3rd IPV dose.
Pt. left shortly after vaccine was administered, felt burning and uneasy but as the weather is hot today dismissed it. As they were driving to another appointment, they noticed the burning sensation increasing with itchiness, welts appearing on mouth and on arms, dizzy. They drove instead to the ED, where the team noted low blood pressure and provided medication (benadryl, etc.). Pt. is scheduled to follow up adverse reaction with provider.
Soreness at site of injection. About 12 hours after the shot I had body aches, chills, headache. I took some Advil to help with aches. I felt better in the morning (24 hrs after shot) but still had a headache and some fatigue.
The pt experienced herpes zoster on right arm with C-6 dermatome on 5/10/01. The pt was seen on 5/15/01, had a fever to 102 that day only. Lesions are healing. Symptoms are treated with acyclovir.
Information has been received from a registered pharmacist concerning a 64 year old female patient with hypertension and penicillin allergy who on 18-APR-2011 was vaccinated subcutaneously in the left arm, with a dose of 0.65 ml ZOSTAVAX (Merck) (Lot #: 669263/1361Z, Exp: 15-JAN-2012). There was no concomitant medication. The pharmacist reported that when the patient removed the band-aid over the injection site, she noticed a small red area at the site underneath the band-aid where she received the injection. Pharmacist was told by the patient that on 20-APR-2011, she noticed that the small red area was larger. The patient went to the pharmacy on 21-APR-2011 and pharmacist reported that the area was hard, raised, warm to the touch and it was two to three inches in size. No treatment was given for the events. No lab/diagnostic studies were performed. At the time of the report, the patient's outcome was not recovered. Additional information has been requested.
left hand swoll up like a reaction to a bee sting; Swelling under right eye, giving an appearance/ Later on that same day,  swelling under left eye, "like a swollen sac"/ the swelling was "almost like a pollen reaction, but not red on the inner eyes, and was non-painful; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Swelling under right eye, giving an appearance of squinty eyes/ Later on that same day,  swelling under left eye, "like a swollen sac"/ the swelling was "almost like a pollen reaction, but not red on the inner eyes, and was non-painful) and PERIPHERAL SWELLING (left hand swoll up like a reaction to a bee sting) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus (DM type 2), Obstructive sleep apnea syndrome (OSA), Chronic bronchitis and Congestive heart failure (CHF). Concomitant products included HCTZ, CARVEDILOL, CHLORTALIDONE (CARVEDILOL + CLORTALIDONA) and AMLODIPINE for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced EYE SWELLING (Swelling under right eye, giving an appearance of squinty eyes/ Later on that same day,  swelling under left eye, "like a swollen sac"/ the swelling was "almost like a pollen reaction, but not red on the inner eyes, and was non-painful). On 10-Mar-2021, the patient experienced PERIPHERAL SWELLING (left hand swoll up like a reaction to a bee sting). The patient was treated with OXYCODONE HYDROCHLORIDE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 11-Mar-2021, PERIPHERAL SWELLING (left hand swoll up like a reaction to a bee sting) had resolved. At the time of the report, EYE SWELLING (Swelling under right eye, giving an appearance of squinty eyes/ Later on that same day,  swelling under left eye, "like a swollen sac"/ the swelling was "almost like a pollen reaction, but not red on the inner eyes, and was non-painful) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 01-Mar-2021, after vaccination on the way home the patient looked in the rearview mirror of his car and noted swelling under his right eye, giving him an appearance of squinty eyes. Later on that same day, he experienced swelling under his left eye, "like a swollen sac." The swelling was "almost like a pollen reaction, but not red on the inner eyes and was nonpainful. It improved with Benadryl but symptoms were still ongoing at the time of reporting. On 10-Mar-2021 night, the patient took a Percocet after which his left hand "swoll up, like a reaction to a bee sting,". After which the patient took benadryl leading to resolution of the left hand swelling as of 11-Mar-2021 morning.
Janssen COVID-19 Vaccine EUA. Fever, chills , nausea, vomiting, diarrhea, headache, muscle aches, extreme weakness, and dizziness in the first 72 hours. The subsequent 72 hours I've experienced diarrhea, extreme dizziness,  body aches, and skin discoloration in the injection site.
This patient was seen on 05/01/01 for routine exam and vaccines. Appt at 4 PM, returned at 5:30 PM with full blown hives. Epinephrine Sq, and Benadryl, po administered. Resolving, NAD, smiling, and happy.
Within one hour, urge to urinate frequently. Painful urination followed and increased. Tolerated until seeing PA on morning of 3/12/2021. PA identified blood in urine and prescribed Notrofurantoin Mono/Mac, 100 mg capsules, 1/day for 7 days. Infection cured.
Tightness in chest, SOB, wheezing and weakness after more than 20 minutes from receiving immunizations. Pt treated with SQ Epi, Solu medrol 125 and Benadryl 50 mg IV and Albuterol med treatment for 3 days.
Fever, Chills, Headache,  Body Ache, Rash at injection site.
Information has been received from a Certified Medical Assistant concerning a 12 year old female patient who on 19-JUN-2007 was vaccinated IM with her first does of Gardasil vaccine, Lot #656051/0244U. concomitant therapy included Menactra and Boostrix. The patient has not had a menstrual period since she received the first dose of Gardasil vaccine on 19-JUN-2007. Unspecified medical attention was sought. At the time of the report the event was ongoing. Additional information has been requested. This is in follow-up to report(s) previously submitted on 11/14/2007.  Information has been received from a licensed practical nurse concerning a 13 year old female patient with no medical history of allergies who on 19-JUN-2007, was vaccinated IM with a first dose of GARDASIL (lot #655051/0244U).  Concomitant therapy included MENACTRA and BOOSTRIX.  The patient has not had a menstrual period since she received the first dose of GARDASIL on 12-JUN-2007.  Unspecified medical attentino was sought.  No laboratory diagnostic studies were performed.  At the time of this report.  The patient's outcome was unknown.  No product quality complaint was involved.  Additional information is not expected.
On 12/19 pt. states she woke up with swelling in hands bilaterally. Pain in wrists & hand joints bilaterally. Called dr Wed 12/24. Prescribed CLARITIN & ENDOCRIN 3 mg x 2 days. Feels sx are slightly decreased at this time 12/27/12 at 0850.
Vaccinated 10/8.  By 10/12 had 3-4 inch area at injection site that was swollen and red. Pain was bad enough to limit ability to lift arm above shoulder level. Swelling resolved within a couple weeks. Pain was in shoulder and left elbow. Saw PCP on 10/27. Inflammatory markers checked and negative. Given a five day prescription of prednisone. Symptoms did not improve. Was referred to orthopedic for arthralgia r/t vaccination and seen 2/8/2022. Diagnosed with bursitis in left shoulder and tennis elbow. Left should injected with 12 mg Celestine and betamethasone acet. Shoulder has reduced pain but elbow does not.
Pt experienced extreme fatigue lasting 7 to 9 days after vaccination. Pt slept long than normal (2.5 hours), pt couldn't stand for long periods of time and when sitting would fall asleep within 15-20 minutes. (This lasted for 2 days.)
Child was very tired and napped longer than usual.  After he woke up he was lethargic and had trouble concentrating.  EMT were called, but did not take child to ER.  Parent will call back tomorrow with update.
: Regarding The Health on the following COVID Vaccine Moderna. Please see the following determination; Doses Administered from 4.6.2021 to 5.21.2021:Based on the information you have provided and the lack of temperature data, we are not able to conduct an analysis or guarantee the doses administered between 4/6/2021 and 5/21/2021 provided the necessary protection against a COVID-19 infection. Please continue with the original plan of action on revaccination and completing a VAERS Reports on the all clients you have identified.
Patient experienced dizziness for 24 hour period following vaccine administration; This is a spontaneous report received from a contactable reporter(s) (Other HCP). A 37-year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 15Apr2021 12:30 (Lot number: ER8730) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DIZZINESS (non-serious) with onset 16Apr2021 12:30, outcome "recovered" (17Apr2021), described as "Patient experienced dizziness for 24-hour period following vaccine administration". Therapeutic measures were not taken as a result of dizziness.  Additional information: It was unknown if patient received any other vaccine in four weeks or not. It was unknown if patient received any other medications in two weeks or not. It was unknown if patient had covid prior vaccination or not. It was unknown if patient had known allergies or not. It was unknown if patient had covid tested post vaccination or not. Patient experienced dizziness for 24-hour period following vaccine administration. The case was assessed as non-serious.  No follow-up attempts are possible. No further information is expected.
Father report that child woke up blind the next morning. He brought her to the clinic & he was instructed to take the child to the emergency room.
About  24 hours later, I suddenly felt ill and feverish. It came out of nowhere. For the next 2 days, I had a 100 degree temperature, extremely painful body aches everywhere, nauseous, no appetite. I called the pharmacist and she told me I was having a reaction to one of the ingredients of the vaccine and it would last 2-3 days. She was right because on day 3, I felt much better. Although, felt tired & still a little sick but I was able to get out and drive. I took lots of Tylenol, phenagrin, used cool packs for my head/forehead and behind neck. In conclusion, it felt like having the flu for 2 days. It was awful!!!
Chest pain for 2 days with elevated troponin levels.  Admitted to pediatric cardiology service.  Cardiac MRI showed findings consistent with myocarditis
Previous to 12 hours after shot, I had slight chills and small pain at injection site. Almost exactly 12 hours later, I had chills and then started feeling worse. When I woke up next morning, I was tired, sore arm, and chills. By that evening, I had a fever (99.1) and was hot all over entire body. I took 2 extra strength Tylenol, cold compresses on forehead, and by next morning, I felt much better. The fever broke overnight while I was sleeping. The worst of the symptoms was 2nd evening with the fever. Today, I feel much better with only soreness in my right arm at injection site.
The pt experienced a piercing cry for 4 hours post vax. This started approximately 2 hours post vax. Tylenon was given 2 hours into screaming with little relief.
Immediately after injection a nodule formed to side of injection site. Bump eventually subsided but area remained swollen and red to touch for 3 days. Now area is still red a week later and slightly itchy
Patient fainted 1 to 2 minutes after immunization. Was pale, unfocused, vomited 3 times over 25 minutes. Complained of headache and dizziness. Fatigue for 5 hours after syncope.
4 days after Flu shot developed neck stiffness, nausea, vomiting, headache neck pain. Treated by PCP IV pain meds IV fluids.
Symptoms began on day of vaccination with headache, felt run-down, fatigued. On 3/24, rash developed around vaccine site. Lymph nodes, tonsils were sore. Spread of rash beyond bandage. On 3/27, chest pressure. Sent to hospital. Cath on 3/31/03 normal. Diagnosed with vaccinia related pericarditis.
Injection given 09-19-2013. Pt noticed a nickel-sized rash to the left of where injection was given, which grew and became weepy. It's now crusting over. This happened approximately 6 months after injection was given. Dr. says it's from ZOSTAVAX inj.
Sudden hearing loss in left ear; This is a spontaneous report from a contactable consumer (patient) via Covid-19 Adverse Event Self-Reporting Solution (COVAES).   A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 05Aug2021 12:45 (lot number: FA7485; expiry date: unknown) at the age of 58-years-old, as dose 2, single for Covid-19 immunization. The patient had no relevant medical history. There were no concomitant medications. The patient previously took FLAGYL 250 and experienced allergies. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, in right arm on 15Jul2021 at 14:00 (lot number: EW0198; expiry date: unknown) at the age of 58-years-old, as dose 1, single, for Covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in Pharmacy or Drug Store.  The patient has not been tested for COVID-19 since vaccination. The patient experienced sudden hearing loss in left ear on 06Aug2021. The patient did not receive treatment for the event. Outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 06-JUL-2016, the patient was inadvertently administered with two doses of PROQUAD, subcutaneously (dose, frequency and lot information were unspecified) that was improperly stored (incorrect product storage), (overdose), (medication error). On 07-JUL-2016, patient again received another dose of PROQUAD. No adverse effect reported. The outcome of the events was unknown. This is one of several reports from the same reporter. Additional information has been requested.
Severe breathing issue.  Rattling in chest.  urgent care on 4/6 and 4/10; enhalers issued, prednisone taken, shot of antibiotic given, chest x-ray.   I flew in to home on 5/1.  On 5/3 started having difficulty breathing progressively got worse went to nurse practioner on Friday, 5/7 sent to diagnostic imaging for ct scan with contrast found bilateral blood clots in lungs.  Sent to ER at Hospital.  Spent 4 days in hospital.  Put on heparin until I was released on Monday.  Put on eliquis when I was released on 5/10.  See hematologist on June 1.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 79-year-old female patient who received SHINGRIX (batch number D3L5G, expiry date 30th June 2019) for prophylaxis. On 7th June 2018, the patient received the 1st dose of SHINGRIX. In June 2018, immediately after receiving SHINGRIX, the patient experienced injection site erythema. In September 2018, the patient experienced shingles. On an unknown date, the outcome of the shingles and injection site erythema were not recovered/not resolved. It was unknown if the reporter considered the shingles and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: Shortly after receiving the dose of SHINGRIX, in the first week of June, the patient developed a red mark at the injection site which looks like a Shingles sore. A few months (3 months) later, the patient was diagnosed with a Shingles outbreak. Shingles outbreak was not directly related to the red mark- the patient developed additional Shingles symptoms (details unknown) besides the injection site reaction, which led to the diagnosis. This diagnosis was made within the last month (September / October). Reporter was uncertain of vaccination date (states first week in June) and uncertain when the red mark first appeared, just that it was soon after that first dose. There had been no improvement in the red mark over the past 4 months, as far as the reporter was aware.
I started experiencing chills about 11 hours after my vaccination, then had a fever during the night. It started around 11 pm or midnight - I didn't take anything for it until 4:30 a.m. when I realized it wasn't going away on its own. Then I took Tylenol and the fever broke about an hour later. No other reactions.
Client had received 2 doses of Pfizer COVID 19 vaccine in past. Requested Moderna for booster dose. Client received dose during a mass clinic. Client immediately after injection had difficulty breathing. Was injected with 0.3 mg of epinephrine. Breathing improved within minutes. EMS was called.  After 3 minutes, began gasping, became disoriented, coughing, palor and nausea. Administered 0.15mg of epinephrine due to all that was available. EMS arrived within minutes and client was taken by ambulance to nearest hospital.